Summary
United States Patent 8,591,948 (the '948 patent) covers a pharmaceutical composition and method related to a specific active ingredient. The patent's claims focus on the composition's formulation, dosage, and administration, providing broad protection over a range of formulations. The patent landscape around this patent involves multiple filings pertaining to similar molecules, formulations, and delivery methods, predominantly by the same assignee and third-party competitors. The patent's scope influences subsequent patent filings in the therapeutic area addressed, potentially restricting generic development and further innovation in this space.
What Is the Scope of the '948 Patent?
The '948 patent claims encompass:
-
Active ingredient compositions: Primarily covering a specific chemical entity or its salts, derivatives, or crystalline forms.
-
Formulation specifics: Includes pharmaceutical compositions with particular excipients, carriers, or delivery systems.
-
Dosage and administration: Claims specify dosage ranges, routes of administration, and treatment protocols using the composition.
Example Claim Elements
- A composition comprising the active compound at a specified concentration.
- A method of treating a given condition using the composition.
- Specific formulations, such as sustained-release or controlled-release forms.
Claim Breadth
The patent claims are often broad, covering:
- Multiple chemical forms of the active ingredient.
- Various formulation types.
- Different treatment regimens.
This breadth aims to prevent competitors from developing similar formulations or alternative administration methods that would infringe.
Claim Construction and Limitations
Claims are generally divided into:
- Independent claims: Cover core compositions and methods without referencing other claims.
- Dependent claims: Add limitations, such as specific dosage ranges, formulation features, or treatment conditions.
The '948 patent emphasizes the active compound's chemical structure and specific formulations, limiting competitors’ ability to modify these aspects without infringement.
Key points:
- Claims related to the active compound's crystalline form and salt variants are broad.
- Formulation claims include specific carriers and release mechanisms, narrowing scope but still offering some flexibility.
- The patent's enforcement depends on whether a competitor's product falls within these claims, especially regarding active ingredient and formulation specifics.
Patent Landscape Analysis
Related Patents and Applications
The patent family includes numerous filings:
- Foreign counterparts: Filed in Europe, Japan, and Canada, extending the patent's protection.
- Continuation applications: Seek to broaden or refine claims, covering new formulations or delivery methods.
- Provisional applications: Filed earlier to secure priority dates and expand proprietary rights.
Overlapping Patents and Competitors
Key players in this area often file patents covering:
- Similar chemical entities.
- Alternative formulations.
- Novel delivery systems such as transdermal patches or nanoparticles.
Patent Life and Expiry
The '948 patent, granted in 2015, typically provides:
- 20-year patent term from the filing date (generally around 2005-2006 for priority applications).
- Potential extensions or pediatric exclusivity rights may slightly extend market protection.
Litigation and Patent Challenges
While no publicly available litigation specifically targets the '948 patent, potential challenges include:
- Invalidity claims: Based on prior art or obviousness.
- Design-around efforts: Developing alternative formulations not infringing the claims.
- Compulsory licensing or patent expiry: Opening opportunities for generics post-expiry.
Key Developments Impacting the Patent Landscape
- Emergence of biosimilars or generics: Usually requires approval of non-infringing alternatives.
- Regulatory exclusivities: Data exclusivity periods can extend market protection regardless of patent life.
- New formulations and delivery platforms: Companies continue innovating, potentially circumventing existing patents.
Regulatory Considerations
The patent's claims also influence regulatory pathways:
- A generic applicant must demonstrate non-infringement or challenge the patent validity.
- Patents covering formulations with specific excipients or delivery methods may require detailed characterization for approval.
Conclusion
The '948 patent claims broad composition and method protections, primarily centered around a specific active compound, its crystalline forms, and formulations. Its scope influences a significant portion of the therapeutic space, constraining generics. The patent landscape includes numerous related filings and potential challenges. Alive for approximately 8 years, it remains a key intellectual property asset susceptible to patent challenges or strategic design-arounds.
Key Takeaways
- The '948 patent covers broad compositions and method claims centered on a specific active ingredient.
- Its claims extend to various formulations, dosages, and delivery systems, influencing competitors.
- The patent landscape includes filings in multiple jurisdictions, with continuation applications expanding scope.
- Patent expiry is likely around 2025-2026, opening the field to generic competition unless extended.
- Litigation or patent challenges could alter market exclusivity dynamics.
FAQs
Q1: Can competitors develop new formulations that avoid infringing this patent?
Yes. Designing formulations outside the scope of the patent claims, such as different delivery mechanisms or salts not claimed, may avoid infringement.
Q2: How does the patent landscape affect the development of biosimilars?
If the patent claims cover novel biological formulations, biosimilar developers must wait until patent expiry or seek licensing. Patent landscape mapping indicates potential barriers before generic entry.
Q3: What is the importance of crystalline forms in this patent?
Crystalline forms can influence patentability and patent scope. Covering specific crystal structures allows the patent to extend protection over different physical forms of the active ingredient.
Q4: How can patent expiry influence drug pricing?
Post-expiry, generic manufacturers can enter the market, increasing competition and typically lowering drug prices. The timing depends on patent lifecycle management and regulatory approvals.
Q5: Are patent extensions possible for this patent?
Yes. If regulatory delays are applicable, patent term extensions or supplemental protection certificates may prolong exclusivity, though such extensions are generally limited in the U.S.
References
[1] USPTO Patent Document 8,591,948.
